The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 24, 2020
Filed:
Jan. 15, 2019
Applicant:
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Inventors:
Daniel DiRocco, Lebanon, NJ (US);
Artis Klapars, Edison, NJ (US);
Edward C. Sherer, Hillsborough, NJ (US);
Assignee:
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 239/00 (2006.01); C07D 421/00 (2006.01); C07D 517/00 (2006.01); C07H 19/10 (2006.01); C07H 19/06 (2006.01); C07H 19/24 (2006.01); C07D 487/04 (2006.01); C07H 9/06 (2006.01); C07H 1/00 (2006.01); C07H 1/02 (2006.01);
U.S. Cl.
CPC ...
C07H 19/10 (2013.01); C07D 487/04 (2013.01); C07H 1/00 (2013.01); C07H 1/02 (2013.01); C07H 9/06 (2013.01); C07H 19/06 (2013.01); C07H 19/24 (2013.01);
Abstract
The present invention is directed to a process for making Chloro-Substituted Nucleoside Phosphoramidate Compounds of formula (I): which are useful for the treatment and prophylaxis of HCV infection. The present invention is also directed to compounds that are useful as synthetic intermediates for making the compounds of formula (I).